Annovis

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Intercept, Annovis and Biohaven Advance Late Phase Trials
BioSpace
Mon, 07/11/22 - 12:00 am
Intercept Pharma NASH
Annovis
buntanetap
Parkinson's Disease
Biohaven
taldefgrobep alfa
SMA